Brief: Unity Biotechnology Reports Qtrly Net Loss Per Share Of $0.30

Unity Biotechnology

10/11/2021 14:27

Nov 10 (Reuters) - UNITY Biotechnology Inc  UBX.O :
    * UNITY BIOTECHNOLOGY, INC. REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS AND BUSINESS UPDATES
    * BELIEVES CURRENT CASH, CASH EQUIVALENTS, AND MARKETABLE
SECURITIES ARE SUFFICIENT TO FUND OPERATIONS THROUGH Q3 OF 2022
    * QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.30
    * Q3 EARNINGS PER SHARE VIEW $-0.37 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9RYPhG 
Further company coverage:  UBX.O 

 ((Reuters.Briefs@thomsonreuters.com;))